Press release
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Key Players Analysis - Johnson & Johnson, Sun Pharmaceutical, CSPC, Teva, Fudan-Zhangjiang.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market - (By Type (Liposomes Drugs, Lipid Nanoparticle Drugs) By Application (Hospital, Retail Pharmacy, Other)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."According to the latest research by InsightAce Analytic, the Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market is valued at US$ 5.4 Bn in 2023, and it is expected to reach US$ 10.8 Bn by 2031, with a CAGR of 9.3% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2459
Liposomes are lipid nanoparticle drug delivery systems, which are technologies that use nanoparticles to administer medical medications in a targeted and controlled manner. Minimizing side effects while reducing dosage and frequency is the goal of current drug delivery systems. There has been a lot of recent buzz about nanoparticles due to their possible use in more effective drug delivery. Liposomes are lipid bilayers that encase an internal cavity with a closed, spherical shell; this shell can contain water or other liquids. In a lipid bilayer, two phospholipid sheets are stacked on each other. With these molecules, one receives a hydrophilic head and a hydrophobic tail.
Hydrophobic tails of merging single membranes are drawn to each other, while hydrophilic heads of both membranes are drawn to the surrounding water. The use of pharmaceutical lipids has the potential to improve medication delivery due to their low toxicity and large action-fusion potential. For this reason, pharmaceutical lipids are a hot commodity in every global market, and experts anticipate rapid growth in the sector in the years ahead. However, high pricing and complicated production processes are two obstacles that the liposomal and lipid nanoparticle drug delivery systems industry confronts.
List of Prominent Players in the Liposomal and Lipid Nanoparticle Drug Delivery Systems Market:
• Johnson & Johnson
• Sun Pharmaceutical
• CSPC
• Teva
• Fudan-Zhangjiang
• Zydus Cadila
• TTY Biopharma
• Pacira
• Luye Pharma
• Leadiant Biosciences
• Ipsen
• Sayre Therapeutics
• Alnylam
• Bausch Health
• Acrotech Biopharma
• Takeda
• Chiesi Farmaceutici
• Gilead Sciences
• Other Market Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
The growing demand for liposomal and lipid nanoparticle drug delivery systems is fueled by the growing number of elderly people and the higher rates of chronic diseases. Nanoparticles have unique properties that make them perfect for treating complex chronic ailments, such as improved permeability and extended circulation. The versatility of nanocarriers allows them to accommodate a wide range of therapeutic chemicals, expanding the scope of nanomedicine's potential uses in areas such as neurology and oncology.
Challenges:
The main obstacle is the inadequate technological expertise, scarcity of skilled persons, and absence of established norms and protocols due to lockdowns and isolation in developing nations, which is expected to impede the growth of the market for liposomal and lipid nanoparticle drug delivery systems. The risk associated with intellectual property and the growing number of pharmaceutical companies establishing their production facilities could pose difficulties for the industry for contract manufacturing of nanoparticles. The expansion of the liposomal and lipid nanoparticle drug delivery systems can be hampered by the growing number of pharmaceutical corporations establishing their production facilities. Disruptions caused by the COVID-19 pandemic have become frequent across industries, including the worldwide nanoparticle contract manufacturing business, since the outbreak. Cleaning and reorganizing work areas to reduce vulnerabilities and increase resilience has been a focus for service providers in combating these difficulties. Collaboration tools have also had to be digitalized to support consumers remotely. Therefore, liposomal and lipid nanoparticle drug delivery companies increasingly lean toward digital solutions to increase their reach and efficiency. This is helping them gradually recover from the recession.
Regional Trends:
The North American liposomal and lipid nanoparticle drug delivery systems market is anticipated to record a large market revenue share. It is projected to grow at a high CAGR in the near future because of its well-developed healthcare system, renowned pharmaceutical and biotechnology companies, and massive R&D expenditures. North America leads the global economy. Besides, Europe had a considerable market share due to a significant growth rate, highlighting environmentally sustainable approaches to nanoparticle production and their application in many industries.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2459
Recent Developments:
• In Dec 2021, Sun Pharmaceuticals Industries announced that one of its fully-owned subsidiaries has obtained final approval from the US FDA for its ANDA (Abbreviated New Drug Application) for a generic version of Amphotericin B Liposome for Injection, with a strength of 50 mg/vial in a single-dose vial. The approval of the generic product is contingent upon the reference product, AmBisome Liposome for Injection, 50 mg/vial.
• In March 2021, Genevant Sciences and Takeda Pharmaceutical Company Limited ("Takeda") have entered into a global collaboration and license agreement for the development, marketing, and discovery of LNP-delivered nucleic acid therapeutics that target drug targets in hepatic stellate cells that were previously inaccessible. The therapeutics are intended to be used to treat liver fibrosis.
Segmentation of Liposomal and Lipid Nanoparticle Drug Delivery Systems Market-
By Type-
• Liposomes Drugs
• Lipid Nanoparticle Drugs
By Application-
• Hospital
• Retail Pharmacy
• Other
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2459
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Key Players Analysis - Johnson & Johnson, Sun Pharmaceutical, CSPC, Teva, Fudan-Zhangjiang. here
News-ID: 3780188 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd

Drone Traffic Management Market Current Scenario with Future Trends Analysis to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drone Traffic Management Market- (By Type (Persistence, Non-Persistence), By Component (Persistence, Non-Persistence), By Solution (Communication Infrastructure, Surveillance Infrastructure, Navigation Infrastructure), By End-User (Communication Infrastructure, Surveillance Infrastructure, Navigation Infrastructure)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Drone Traffic Management Market is valued at US$ 110.12…

DNA Synthesizer Market Exclusive Report on Current Trends and Future Insights to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global DNA Synthesizer Market Size, Share & Trends Analysis Report By type (benchtop DNA synthesizers and large-scale DNA synthesizers), application (drug discovery & development, genetic engineering, and clinical diagnostics) and end users (academic & research institutes, pharmaceutical & biotechnology companies and clinical laboratories.), Region, Market Outlook And Industry Analysis 2031"
The global DNA synthesizer market is estimated…

DNA/RNA Sample Extraction and Isolation Market Latest Trends and Growth Factors …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global DNA/RNA Sample Extraction and Isolation Market- (By Product (Consumables (Kits (DNA Kits, RNA Kits), Reagents), Instruments), By Technology (Consumable-Based Technology (Silica-Based, Magnetic Particle Technology, Other Technologies), Instrument-Based Technology (Automated Spin Column-Based, Magnetic Bead-Based, Automated Liquid Handling), By Application (PCR, NGS, Cloning, Microarray, Blotting Techniques, Other Applications), By End-User (Clinical Diagnostic and Forensic Laboratories, Research Academics…
DNA Origami Market Investments, Share and Revenue Analysis Report to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global DNA Origami Market Size, Share & Trends Analysis Report By Type (Single-stranded Scaffold DNA, Folding Kits, Staple Strand Oligos), By Structure (Static, Active), By Application (Nanorobots and fluorescence studies, Enzyme-substrate studies)- Market Outlook And Industry Analysis 2031"
The Global DNA Origami Market is estimated to reach over USD 88.09 million by 2031, exhibiting a CAGR of…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…